Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

March
03
2020

Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radio Therapy in Journal of Drugs in Dermatology

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical…

February
19
2020

The Prevalence of Skin Cancer in Transplant Patients

Skin cancer is the most common cancer found in organ transplant recipients. Patients who have received organ transplants are at risk of developing skin cancer. Specifically, 65% more likely than people without transplants. Moreover, in…

February
18
2020

States With The Highest Risk for Melanoma

This is taken from an article posted on CNN.com written by Shelby Lin Erdman dated 02/18/2020: (CNN) – States with the highest rates of melanoma cases linked to ultraviolet radiation are spread across the United…

February
14
2020

Non-Melanoma Skin Cancer Outcomes

Dr. William Roth presents three cases of non-melanoma skin cancer being treated by Superficial Radio Therapy (SRT). Look at these amazing results!

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry